Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 12, 1999
Domains responsible for constitutive and Ca(2+)-dependent interactions between calmodulin and small conductance Ca(2+)-activated potassium channels
J E Keen, R Khawaled, D L Farrens, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 31, 1997
Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium
J R Horowitz, A Rivard, R van der Zee, et al.
Nature
|
October 17, 1998
Mechanism of calcium gating in small-conductance calcium-activated potassium channels
X M Xia, B Fakler, A Rivard, et al.
Gene Therapy
|
June 23, 2006
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment
D J Stewart, J D Hilton, J M O Arnold, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 12, 1999
Domains responsible for constitutive and Ca(2+)-dependent interactions between calmodulin and small conductance Ca(2+)-activated potassium channels
J E Keen, R Khawaled, D L Farrens, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 31, 1997
Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium
J R Horowitz, A Rivard, R van der Zee, et al.
Nature
|
October 17, 1998
Mechanism of calcium gating in small-conductance calcium-activated potassium channels
X M Xia, B Fakler, A Rivard, et al.
Gene Therapy
|
June 23, 2006
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment
D J Stewart, J D Hilton, J M O Arnold, et al.
Page
of 3